KRT19 and neoplasm: CK19 (+) HCCs are not only associated with early tumor recurrence and poor overall survival after hepatectomy or liver transplantation, but are also resistant to chemotherapy and local treatment as compared to CK19 (-) HCCs [6,19,20,21].